Alex Fuchs
Director of Product Innovation
Single Use Support
Colder Products Company
Panelist
Alex Fuchs
Alexander Fuchs is the director of product innovation at Single Use Support. Due to his highly technical education and intensive insights, he has a wide range of experience and knowledge in various industries, such as jewelry, manufacturing, and biopharma, as well as multiple areas of activity. Passionate about automation, engineering, and process management, Alexander contributes to the innovative focus of advancing fluid and cold chain management within the biopharmaceutical industry.
Jascha Rosenbaum
Regional Director for Applications & Business Development
Colder Products Company
Panelist
Jascha Rosenbaum
Jascha Rosenbaum is the regional director for applications and business development in Europe. Jascha holds a master’s degree in chemical engineering, and he has worked in the single-use industry for the last 10 years in both the U.S. and Europe. He has supported some of the largest biopharmaceutical manufacturers across Europe, where he has experience at every stage of single-use solutions.
Broadcast Date:
- Time:
In cell and gene therapy manufacturing, fluid transfer and freeze-thaw workflows are paramount to process efficiency, product quality, and operational flexibility. From scaling and closed-system processing to automation and the growing use of cryopreservation, manufacturers are rethinking how materials move through the process—both during manufacturing and between unit operations.
In this GEN webinar, our expert speakers will discuss the latest trends, challenges, and innovations shaping fluid transfer and freeze-thaw workflows. The panel will explore how cell and gene therapy manufacturers are addressing complex process requirements while reducing manual interventions, minimizing contamination risk, improving workflow efficiency, and preparing processes for scale. Key takeaways from the webinar include:
- Emerging approaches to fluid transfers,
- Single-use technologies and sterile connections,
- Freeze-thaw considerations,
- Automation and closed processing,
- Strategies for building more flexible and robust workflows for cell and gene therapy manufacturing
A live Q&A session will follow the conversation offering you a chance to pose questions to our expert panelists.
Produced with support from:
